BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35253201)

  • 1. Bayesian sample size determination using commensurate priors to leverage preexperimental data.
    Zheng H; Jaki T; Wason JMS
    Biometrics; 2023 Jun; 79(2):669-683. PubMed ID: 35253201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian sample size determination using commensurate priors to leverage pre-experimental data.
    Zheng H; Jaki T; Wason JMS
    Biometrics; 2022 Mar; 79(2):669-683. PubMed ID: 38523700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian sample size determination in basket trials borrowing information between subsets.
    Zheng H; Grayling MJ; Mozgunov P; Jaki T; Wason JMS
    Biostatistics; 2023 Oct; 24(4):1000-1016. PubMed ID: 35993875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.
    Harun N; Liu C; Kim MO
    Pharm Stat; 2020 Sep; 19(5):613-625. PubMed ID: 32185886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propensity score-integrated Bayesian prior approaches for augmented control designs: a simulation study.
    Wang X; Suttner L; Jemielita T; Li X
    J Biopharm Stat; 2022 Jan; 32(1):170-190. PubMed ID: 34939894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporating individual historical controls and aggregate treatment effect estimates into a Bayesian survival trial: a simulation study.
    Brard C; Hampson LV; Gaspar N; Le Deley MC; Le Teuff G
    BMC Med Res Methodol; 2019 Apr; 19(1):85. PubMed ID: 31018832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bayesian Sample Size Estimation Procedure Based on a B-Splines Semiparametric Elicitation Method.
    Azzolina D; Berchialla P; Bressan S; Da Dalt L; Gregori D; Baldi I
    Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36361129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust meta-analytic-predictive priors in clinical trials with historical control information.
    Schmidli H; Gsteiger S; Roychoudhury S; O'Hagan A; Spiegelhalter D; Neuenschwander B
    Biometrics; 2014 Dec; 70(4):1023-32. PubMed ID: 25355546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian sample size determination for phase IIA clinical trials using historical data and semi-parametric prior's elicitation.
    Berchialla P; Zohar S; Baldi I
    Pharm Stat; 2019 Mar; 18(2):198-211. PubMed ID: 30440109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal sample size determination for single-arm trials in pediatric and rare populations with Bayesian borrowing.
    Ji Z; Lin J; Lin J
    J Biopharm Stat; 2022 Jul; 32(4):529-546. PubMed ID: 35604836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A scaled kernel density estimation prior for dynamic borrowing of historical information with application to clinical trial design.
    Warren JL; Wang Q; Ciarleglio MM
    Stat Med; 2024 Apr; 43(8):1615-1626. PubMed ID: 38345148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Historical controls in clinical trials: a note on linking Pocock's model with the robust mixture priors.
    Callegaro A; Galwey N; Abellan JJ
    Biostatistics; 2023 Apr; 24(2):443-448. PubMed ID: 37057610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian borrowing from historical control data in a vaccine efficacy trial.
    Peng L; Jin J; Chambonneau L; Zhao X; Zhang J
    Pharm Stat; 2023; 22(5):815-835. PubMed ID: 37226586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian consensus-based sample size criteria for binomial proportions.
    Joseph L; Bélisle P
    Stat Med; 2019 Oct; 38(23):4566-4573. PubMed ID: 31297825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
    Hupf B; Bunn V; Lin J; Dong C
    Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample Size Requirements for Calibrated Approximate Credible Intervals for Proportions in Clinical Trials.
    De Santis F; Gubbiotti S
    Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33445651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian clinical trial design using historical data that inform the treatment effect.
    Psioda MA; Ibrahim JG
    Biostatistics; 2019 Jul; 20(3):400-415. PubMed ID: 29547966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Borrowing of information across patient subgroups in a basket trial based on distributional discrepancy.
    Zheng H; Wason JMS
    Biostatistics; 2022 Jan; 23(1):120-135. PubMed ID: 32380518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint control of consensus and evidence in Bayesian design of clinical trials.
    De Santis F; Gubbiotti S
    Biom J; 2022 Apr; 64(4):681-695. PubMed ID: 34889467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian selective response-adaptive design using the historical control.
    Kim MO; Harun N; Liu C; Khoury JC; Broderick JP
    Stat Med; 2018 Nov; 37(26):3709-3722. PubMed ID: 29900577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.